首页 | 本学科首页   官方微博 | 高级检索  
检索        

多奈哌齐治疗阿尔茨海默病临床疗效分析
引用本文:曾桄伦,张红雨.多奈哌齐治疗阿尔茨海默病临床疗效分析[J].中华神经医学杂志,2004,3(4):282-283.
作者姓名:曾桄伦  张红雨
作者单位:佛山市第一人民医院神经内科,广东,佛山,528000
摘    要:目的 探讨多奈哌齐对阿尔茨海默病治疗的有效性及安全性。方法 采用分组对照,治疗组给予多奈哌齐及脑复康治疗16周,对照组只给予脑复康治疗。治疗前后采用AD评定量表的认知次级量表(ADAS-cog)和简易智能精神状态检查量表(MMSE)评价患者认知功能、精神行为及痴呆严重程度结果多奈哌齐治疗组患者较对照组患者ADAS-cog及MMSE评分改善明显,而对照组患者评分无明显改变。治疗患者无明显药物副作用。结论 多奈哌齐可以安全地用于治疗阿尔茨海默病。

关 键 词:多奈哌齐  阿尔茨海默病  乙酰胆碱  乙酰胆碱酯酶  不良反应  老年
文章编号:1671-8925(2004)04-0282-002
修稿时间:2004年1月12日

Analysis on clinical therapeutic effect of donepezil in treating Alzheimer's disease
ZENG Guanglun,ZHANG Hongyu.Analysis on clinical therapeutic effect of donepezil in treating Alzheimer''''s disease[J].Chinese Journal of Neuromedicine,2004,3(4):282-283.
Authors:ZENG Guanglun  ZHANG Hongyu
Institution:ZENG Guanglun,ZHANG Hongyu Department of Neurology,First People's Hospital of Foshan City,Foshan 528000,China
Abstract:Objective To investigate the validity and safety of donepezil in treating Alzheimer's disease. Methods 33 cases of Alzheimer's disease were divided randomly into treatment group (18) and control group (15). Treatment group were treated with donepezil and piracetam for 16 weeks, while control group with piracetam only. Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-cog) and Mini Mental State Examination (MMSE) were used to evaluate the patients' cognitive function, mental behavior and dementia severity before and after treatment. Results ADAS-cog and MMSE scores of donepezil treatment group were better significantly than those of control group, and the scores of control group have no remarkable difference between pre- and post-treatment. No obvious drug side effect happened on the patients in treatment group. Conclusion Donepezil can be securely used in the therapy of Alzheimer's disease.
Keywords:donepezil  Alzheimer's disease  anticholinesterase
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号